William F. Rencher - Feb 15, 2022 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Former Section 16 officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 03:48 PM
Previous filing
Dec 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +8K $0.00 8K Feb 15, 2022 Common Stock 8K $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

William F. Rencher is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022.